WATSON 746 (Clonazepam 0.5 mg)

Pill imprint WATSON 746 has been identified as Clonazepam 0.5 mg.

Clonazepam is used in the treatment of anxiety; bipolar disorder; panic disorder; benzodiazepine withdrawal; insomnia (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Clonazepam 0.5 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Images for WATSON 746 (Clonazepam 0.5 mg)

Clonazepam 0.5 mg WATSON 746
Clonazepam 0.5 mg WATSON 746
Clonazepam
Imprint:
WATSON 746
Strength:
0.5 mg
Color:
Yellow
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Benzodiazepine anticonvulsants
Benzodiazepines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0746
Inactive Ingredients:
docusate sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium benzoate
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55289-0599 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)